RE: BNC should follow up with this piece at YahooBNC needs to do a quick study to see if Econiche will work on this new strain of E. coli.
If it does, can you imagine how the world will receive such a potent wide-spectrum E. coli vaccine?
If it does not, a lot of questions will have to be raised about the marketability of Econiche. Perhaps, the mutation process of E. coli has passed us by.
This study is very important to the future of Econiche.